Pseudo tumor pelvic actinomycosis revealed by colonic obstruction with hydronephrosis: Can extensive surgery be avoided? A case report

Abstract

Pelvic actinomycosis with an intrauterine device accounts for approximately 3% of all actinomycoses. It is a chronic infectious disease characterized by infiltrative, suppurative, or granulomatous inflammation, sinus fistula formation, and extensive fibrosis, and caused by filamentous, gram-positive, anaerobic bacteria called Actinomyces israelii. The slow and silent progression favors pseudo tumor pelvic extension and exposes the patient to acute life-threatening complications, namely colonic occlusion with hydronephrosis. Preoperative diagnosis is often difficult due to the absence of specific symptomatology and pathognomonic radiological signs simulating pelvic cancer. We discuss the case of a 67-year-old woman who complained of pelvic pain, constipation, and weight loss for 4 months, and who presented to the emergency department with a picture of colonic obstruction and a biological inflammatory syndrome. The computed tomography scan revealed a suspicious heterogeneous pelvic mass infiltrating the uterus with an intrauterine device, the sigmoid with extensive upstream colonic distension, and right hydronephrosis. The patient underwent emergency surgery with segmental colonic resection and temporary colostomy, followed by antibiotic therapy. The favorable clinical and radiological evolution under prolonged antibiotic therapy with the almost total disappearance of the pelvic pseudo tumor infiltration confirms the diagnosis of pelvic actinomycosis and thus makes it possible to avoid an extensive and mutilating surgery with important morbidity.

Keywords

antibiotics bowel obstruction hydronephrosis intrauterine device pelvic actinomycosis surgery

Introduction

Actinomycosis is a rare, chronic, infectious disease characterized by infiltrative, suppurative, or granulomatous inflammation, sinus fistula formation, and extensive fibrosis and caused by filamentous, gram-positive and anaerobic bacteria called the A israelii, described for the first time by Israel in 1978.^1,2 Actinomycosis occurs most commonly in the cervicofacial region (50%–65%), followed by the thoracic (15%–30%) and abdominopelvic (20%) regions but rarely involves the central nervous system.³ Pelvic actinomycosis accompanied by intrauterine device (IUD) accounts for about 3% of all actinomycosis.⁴ Although uncommon, a long duration of IUD appears to confer the greatest risk.¹ The rarity of this pathology, the absence of specific symptoms as well as the pseudotumoral clinical and radiological presentation makes preoperative diagnosis raise a challenge.

Case presentation

A 67-year-old woman, gravida 3 para 3 with no preceding chronic disease or constant medication complained of increasing pelvic pain and constipation associated with weight loss and fatigue for 4 months. The patient’s medical history included the insertion of a copper IUD 30 years ago. The patient was referred to emergency for the worseness of abdominal pain and distension with a frank cessation of intestinal transit and vomiting suggesting a neoplasic intestinal occlusion.

At admission, the vital signs were stable, and the patient was apyretic. Physical examination revealed a mild tenderness at the lower quadrants with abdominal distension without a palpable mass. No signs of inflammation in the cervical or vaginal mucosa were found on gynecological examination. Laboratory investigations demonstrated anemia (hemoglobin: 9 g/dL), raised C-reactive protein (CRP) at 140 mg/L, and high white blood cell (WBC) count (12.3 × 10³/μL). Serum levels of carcino-embryonic antigen (ACE) and CA19-9 and CA 125 were also within the normal range.

The abdominopelvic computed tomography (CT) revealed a 75 × 61 mm heterogeneous pelvic mass with poorly defined margins comprising cystic areas and involving the uterus with an IUD, adnexa, and rectosigmoid colon, which caused right hydronephrosis by compression on the ureter and important colonic distension (Figure 1).

Figure 1.

Pretreatment CT scan with an injection of contrast product: (a) coronal section: poorly limited heterogeneous pelvic mass comprising fluid compartments encompassing the uterus with an intrauterine device (yellow star) and compression of the right ureter (red arrow) responsible for significant dilation of the urinary cavities. (b) Oblique coronal slice and (c) axial slice: heterogeneous pelvic mass sheathing the sigmoid (red arrow) with significant colonic distension.

Initial treatment consists of fluid resuscitation of the patient, correcting the electrolyte abnormalities, and gastrointestinal decompression with a nasogastric tube placed to suction, as well as close monitoring of urine production. Due to the deterioration of her symptoms, the inflammatory syndrome, the debutant renal failure, and hydroelectrolytic disorders she required an emergency surgical procedure.

We performed exploratory laparotomy for debulking. The intraoperative findings were no ascites and no obvious abnormalities in the peritoneum or the surface of the intestine of the middle abdomen. There was a pelvic mass conglomerated with the uterus, adnexa, and distal colon with tight adhesion between the mass and pelvic organs including the small and large bowels and the bladder which could not be dissected out. It involves the right ureter, the rectosigmoid, and caused ureteral dilatation and significant colonic distension with signs of early ischemia. Dissection into the pelvis was impossible due to inflammatory phenomena giving an appearance of pelvic shielding and surgery was considered to be debilitating and morbid in this emergency setting. Based on these findings, a locally advanced ovarian process has been suggested; we performed decompression of the bowel with proximal loop colostomy.

After 2 weeks of metronidazole 4 × 500 mg intravenous (IV) and ceftriaxone 1 × 2 g IV treatment, her WBC was 7500 mm³/mL and CRP was 10 mg/dL. She was then switched to oral amoxicillin 500 mg three times daily. A repeat CT scan, after 4 weeks of antibiotic therapy, showed a resolution of the right hydronephrosis and a reduction in the volume of the pelvic mass with the persistence of a latero-uterine fibrous residue (Figure 2). Post-operative endoscopy did not reveal any suspicious intramucosal lesions. The initial clinical and radiological presentation, as well as the favorable evolution under antibiotic therapy, were considered to support the diagnosis of pelvic actinomycosis and justified the continuation of oral antibiotic therapy for 6 months. She had neither gynecologic nor bowel complaints during the follow-up period until the reversal of the colostomy.

Figure 2.

CT scan with an injection of contrast product after antibiotic treatment. Axial section (a) shows the regression of the dilation of the right renal cavities and (b) of the size of the pseudo pelvic mass with the persistence of a right latero-uterine fibrous residue (red dashed circle).

Discussion

Pelvic actinomycosis is considered to be a rare disease, although the use of IUDs can promote its appearance and was identified as a predisposing risk factor. The colonization rate increases with the duration of its maintenance.^2,5 Vasilesco et al.⁶ reviewed the medical records of 28 patients with abdominopelvic actinomycosis (9 men and 19 women) and the cause of actinomycosis in the studied group was an IUD device in 17 cases from which, 6 patients were admitted because they mimicked a complicated abdominopelvic malignant ovarian advanced ovarian cancer. To reduce the occurrence of this affection, it is recommended that IUDs be changed periodically, every 3–5 years. Nevertheless, some patients may be affected even after the removal of an IUD because of various degrees of endometrial damage caused by stimulation from the IUD and flora disorders.⁷

The clinical presentation is variable depending on the primary site and the duration of the infection and represents a challenge to clinicians in distinguishing pelvic actinomycosis from intraabdominal or pelvic malignancies. However, common symptoms include abdominal pain with or without palpable mass, body weight loss, fever, constipation or diarrhea, vaginal discharge, and symptoms related to bowel obstruction or obstructive uropathy.^8
–11 In our cases, abdominopelvic pain associated with weight loss constituted the prominent chronic symptoms preceding bowel occlusion.

Laboratory parameters commonly revealed anemia, leukocytosis, high values of CRP, and elevated erythrocyte sedimentation rate which was the case with our patient.^12,13 Moreover, some authors reported that tumor marker values like CA125 and alpha-fetoprotein are usually within the reference ranges or slightly elevated.¹¹

The positive diagnosis is bacteriological and/or pathological.¹⁴ However, bacteriological diagnosis is difficult due to the sensitivity of Actinomyces to oxygen, the difficulty of its culture, and its frequent association with other anaerobic bacteria; in fact, its identification is only made in 50% of cases.^14,15 It has been reported that the rate of preoperative diagnosis is less than 10% and most were diagnosed posteriorly on the anatomopathological examination surgical specimen obtained after the performance of a laparotomy or a laparoscopy to evaluate the suspicious pelvic mass.^7,16

Despite the lack of diagnostic specificity, the role of the CT scan remains essential to evoke the diagnosis of pelvic actinomycosis, to specify its extent and its impact on the neighboring organs, and to evaluate the effectiveness of the treatment. CT scan results of an infiltrating abdominopelvic mass without border limits and increased heterogeneous contrast may suggest actinomycosis, especially in patients with fever, leukocytosis, or predisposing factors.⁶ Triantopoulou described the different aspects of abdominopelvic actinomycosis of 18 patients on cross-sectional imaging and indicated discriminative findings from other inflammatory or neoplastic diseases. In this study, 11 female patients had a history of using IUDs and CT findings confirmed the infiltrative nature of the disease, which tended to invade across tissue planes and boundaries. In 11 patients, an inflammatory mass involving the uterus and ovaries was revealed.¹⁰ In 17 cases, peritoneal or pelvic mass involving the bowl appeared to be predominantly cystic and heterogeneously enhanced which was the same radiological presentation of our patient. The authors suggested that this radiological aspect reflects the histologic features of actinomycosis: central suppurative necrosis surrounded by granulation tissue and intense fibrosis. Moreover, many authors reported that hydronephrosis with ureteral obstruction is related to the presence of an IUD in most cases and can be relieved by antibiotic medication and transient insertion of a ureteral stent.^{9,11,17
–19} Lee et al.²⁰ assessed the radiological feature of 18 of gastrointestinal actinomycosis and reported perirectal, pericolic, or pericentric infiltration in 17 patients (94%). Moreover, the urinary tract was involved in 9 patients (50%), with hydronephrosis and hydro-ureter in 6 and hydro-ureter in 3; in all of these patients, ureteral obstruction was caused by the extension of the peritoneal or pelvic mass or inflammatory infiltration. These findings confirm the aggressive behavior of this disease simulating a malignant process. Such a pattern may be attributed to the proteolytic enzyme produced by A israelii.² Moreover, some investigators suggested that patients with elevated CRP, decreased hemoglobin, increased erythrocyte sedimentation rate, and slightly increased CA125 can have renal pelvis dilation or hydronephrosis.⁷ Our patient presented anemia and elevated CRP with normal tumor marker and the CT scan had objectified the local urinary and digestive impact of actinomycosis resulting in hydronephrosis and colonic occlusion. Another interesting radiological finding in our patient was the absence of lymphadenopathy contrasting with the initial appearance evoking locally advanced ovarian cancer which supported the diagnosis of actinomycosis. Regional lymphadenopathy is uncommon or develops late as the organism of actinomycosis usually does not spread via the lymphatic system because of the size of the bacterium.^10,20,21

The usual treatment of actinomycosis is based on high and prolonged doses of penicillin G (20 million units per day) or amoxicillin for 4–6 weeks, followed by penicillin V (4 g per day) orally for 6 to 12 months.¹³ In case of penicillin allergy, macrolides, cyclins, or rifampicin can be used. In addition, it has been observed that actinomycosis is also sensitive to third-generation cephalosporins, ciprofloxacin, and trimethoprim-sulfamethoxazole.^5,8,22 Surgical treatment is usually proposed due to the difficulty in diagnosis and also in case of persistent disease and the occurrence of complications such as bowel obstruction and fistula.^13,22 This combination of surgery and antibiotics results in healing in the majority of cases (Table 1) which was the case of our patient as the colostomy was indicated to remove the occlusion, and the antibiotic therapy had made it possible to treat inflammatory and infectious phenomena and to free the urinary tract.

Table 1.

Case report studies on pelvic actinomycosis.

References	Number of cases	Age	Clinical and radiological presentation	Management
Elhassani et al.²	3 cases	45 years	IUD (5 years) Fever, fecaluria, hematuria CT scan: Bilateral pelvic mass, hydronephrosis, rectal and bladder fistula, liver metastasis simulating in ovarian cancer	Hysterectomy + bilateral oophorectomy + colostomy + penicillin G (18 million units/day) for 6 weeks, followed by amoxicillin (6 g/day) orally for 9 months
		51 years	IUD (7 years) Bowel obstruction CT scan: cystic ovarian mass invading the rectum and bladder	Hysterectomy + bilateral oophorectomy + Penicillin G (18 million units/day) for 6 weeks, followed by Penicillin V 4 million orally for 12 months
		52 years	IUD (15 years) Pelviperitonitis with pelvic tumor syndrome CT scan: bilateral latéro-uterine cystic mass	Hysterectomy + bilateral oophorectomy + peritoneal biopsy Penicillin G (18 million units/day) for 4 weeks, followed by amoxicillin (6 g/day) orally for 9 months
Saad et al.⁵	1 case	38 years	IUD (10 years) Abdominal pain, weight loss, anorexia biological inflammatory syndrome CT scan and MRI: a large fluid collection underlining the anterior abdominal wall at the false pelvic cavity, as well as parietal peritoneal enhancement and smudging of the mesenteric fat and a bulky fibroid uterus with an implanted IUD	Laparoscopy and peritoneal biopsy Ceftriaxone 2 g/day for 6 weeks before switching to doxycycline 100 mg × 2/day orally for 3 months
Vasilescu et al.⁶	28 cases (9 men and 19 women)	43.36 ± 19.14 years (18–64 years)	IUD: 13 patients Clinical feature: • Distended abdomen with tenderness 11/28 (39.2%) • Tumor palpable 4/28 (14.2%) • Deep organ adhesion 12/28 (42.3%) • Abdominal pain 18/28 (76.9%) • Fever 17/28 (61.5%) • Weight loss 14/28 (50%) • Anemia 13/28 (46.4%) • Leukocytosis 23/28 (82.14%) • Imaging (US, CT): • Intraperitoneal collections 11/28 (39.2%)—A heterogeneous mass involving the colon 6/28 (21.4%) • Omental mass 3/28 (10.7%) • Inflammatory mass involving the ovaries 6/28 (21.4%) • Right liver abscesses 2/28 (7.1%)	Open approach 6/28 (21.4%): • Right hemicolectomy 3/6 (50%) • Segmental colectomy 2/6 (33.3%) • Drainage of peritoneal abscess 1/6 (17.6%) Laparoscopic approach 21/28 (21.4%) • Omental laparoscopic resection 3/21 (14.2%) • Right hemicolectomy 1/21 (4.7%) • Bilateral salpingo-oophorectomy 6/21 (28.5%) • Drainage of peritoneal abscess 11/21 (5.2%) • Drainage and biopsy of the liver abscess 1/21 (4.7%) Radiologic percutaneous approach of the liver abscess 1/28 (3.5%) Intravenous penicillin for 4–6 weeks (12 to 20 million units daily in divided doses every 4 to 6 h) + amoxicillin oral
Najib et al.¹⁶	1 case	49 ans	IUD (20 years) Pelvic pain, weight loss Biological inflammatory syndrome CT scan/MRI: Bilateral ovarian multiloculated cystic lesions with multiple anterior pelvic implants in the utero-vesical space evoking peritoneal carcinomatosis. Pelvic lymphadenopathies	Total abdominal hysterectomy with bilateral salpingo-oophorectomy + partial cystectomy + cecal resection + sigmoidal wedge resection and partial omentectomy Intravenous ampicillin during hospital stay followed by ampicillin 1 g day for 6 months
Han et al.⁷	1 case	54 years	IUD (removed 6 months before surgery) bilateral lower abdominal tenderness, anorexia, vomiting, constipation, and pelvic masses Anemia, renal failure CT scan, MRI: solid pelvic mass with an irregular shape, which occupied nearly all of the pelvic cavity, bilateral hydronephrosis	Total hysterectomy with bilateral adnexectomy, ureteric stent Penicillin (20 million U, iv gtt) for 14 days
Morais-kansaon et al.²²	1 case	46 years	IUD Abdominal pain, dysuria CT scan: contrast-enhancing mass lesion measuring 3.2 × 3.6 × 2.8 cm with irregular and poorly defined contours in the middle third of the transverse colon. Extension to omental fat and anterior abdominal wall suggesting a gastrointestinal stromal tumor or adenocarcinoma of the colon	Transverse colectomy, omentectomy, and retroperitoneal lymphadenectomy Intramuscular benzathine benzylpenicillin 12 million UI/day for 6 weeks followed by oral ampicillin 2 g/day for 3 months
Saramago et al.⁸	1 case	47 years	IUD (6 years) Pelvic mass, anemia Colonoscopy: concentric infiltrative rectal lesion CT scan/MRI: a large solid heterogeneous pelvic solid mass with cystic areas, left hydronephrosis and iliac lymph node enlargement simulating an ovarian cancer or a colorectal cancer	Ureteric stent, total hysterectomy, and bilateral salpingo-oophorectomy Intravenous penicillin (5 million units/6 h) for 4 weeks, followed by oral doxycycline for 12 months
Laios et al.⁹	2 cases	57 years	IUD (9 years) Abdominal pain, vaginal discharge, weight loss, anorexia, dysuria and constipation CT scan: Bilateral complex, predominantly cystic pelvic masses involving the right rectus abdominis muscle, ascitis, generalized peritoneal disease and sigmoid involvement suggesting an ovarian cancer	Total hysterectomy and bilateral salpingo-oophorectomy, omentectomy, bladder peritonectomy, rectosigmoid resection with re-anastomosis and excision of an anterior abdominal wall tumor. intravenous benzylpenicillin 1.8 mg/4 h for a total of 6 weeks followed by Oral amoxicillin 500 mg 3 times daily for 12 months
Laios et al.⁹	2 cases	37 years	IUD (4 years) Abdominal pain, weight loss, pyrexia, night sweats, anorexia and altered bowel habits CT scan: complex right adnexal mass and an heterogeneous presacral mass invading the rectum. Multiple smaller masses consistent with metastatic disease, bilateral hydronephrosis, ascites, left pleural effusion suggesting un ovarian cancer.	Peritoneal biopsy Intravenous benzylpenicilline 1.8 mg 4-hourly followed by IV ceftriaxone 2 g daily for 6 weeks switched to oral amoxicillin 500 mg×3/ day for 6 months
Nissi et al.¹²	1 case	45 years	IUD (24 years) Bowel obstruction CT scan: Dilated colon upstream of a narrowed colon segment at flexura lienalis. There was tissue infiltration surrounding the bowel stricture as well as separate omental infiltration proximal and distal to the obstruction site. An enhancing cystic lesion in the right ovary. There were also increased number of lymph nodes in paraaortil space and omentum	Expanded hemicolectomy and jejunal resection + a right-side salpingo-oophorectomy. Intravenous penicillin (20 mega units/day) and per oral metronidazole (1.5 g/day) for 7 weeks followed by oral amoxicillin (1.5 g/day) for 6 months
Lee et al.¹¹	1 case	42 years	IUD (8 ans) Pelvic discomfort, pelvic mass and constipation, anemia CT scan: pelvic mass extending into the uterus, adnexa, rectosigmoid colon and bladder walls with hydronephrosis suggesting an ovarian cance	Total hysterectomy, bilateral salpingo-oophorectomy, low anterior resection with reanastomsis and appendectomy and ileostomy. intravenous penicillin G (15 × 106 IU) for 4 weeks and oral penicillin for additional 6 months
Akhan et al.¹⁹	3 cases	38 years	No IUD Pelvic mass, weight loss MRI: a 6-cm heterogeneous solid masses with focal areas of diminished attenuation in the left adnexal area as well as right-side involvement. A 3-cm solid mass in the right adnexal area infiltrating the right ureter	Total hysterectomy, bilateral salpingo-oophorectomy, infracolic omentectomy, appendectomy, peritoneal washing, and peritoneal abscess drainage. intravenous high-dose penicillin treatment for 6 months
		37 years	No IUD Left-sided mass, fatigue MRI: cystic lesion of 8 cm lateral to the right-sided hydronephrosis expanding to the pelvic rim, both ureters dilated, rectal invasion and irregular soft-tissue densities lying retroperitoneally suggesting retroperitoneal fibrosis	Colectomy and temporary diverting sigmoid colostomy + ureteric stent Ceftriaxone and metronidazole
		51 years	No IUD Pelvic mass, constipation, nausea CT scan: a 8-cm mass with poorly defined margins constricting the rectal lumen and infiltrating the perirectal space	Colectomy and sigmoid loop colostomy + total abdominal hysterectomy and bilateral salpingo-oophorectomy Intravenous ampicillin 4 × 1 g/day during 14 days followed by 6 months of oral penicillin
Mnif et al.¹⁴	2 cases	41 years	IUD (8 ans) Pelvic mass, anemia, biological inflammatory syndrome CT scan: right laterouterine mass of mixed cystic and tissue density suggestive of ovarian malignancy	A right salpingo-oophorectomy + appendectomy Amoxicillin-clavulanic acid + metronidazole followed by extencillin
Mnif et al.¹⁴	2 cases	45 years	IUD (4 years) pelviperitonitis and septic shock	Bilateral salpingo-oophorectomy Penicillin G
Nasu et al.¹⁷	1 case	63 years	IUD (30 years) Lower abdominal pain and slight fever CT scan: soft-tissue mass in continuity with the uterus filling the presacral space with extension to the sigmoid colon, urinary bladder, and right ureter. Right hydronephrosis	Total hysterectomy, bilateral salpingo-oophorectomy. Benzyl penicillin administration (10,000,000 IU/day for 4 weeks) followed by oral ampicillin (1200 mg/day) for 6 months
Present case	1 case	67 years	IUD (30 years) Bowel obstruction, anemia, biological inflammatory syndrome, renal failure CT scan: heterogeneous pelvic mass with poorly defined margins comprising cystic aereas and involving the uterus with an IUD, adnexa and rectosigmoid colon, which caused right hydronephrosis by compression on the ureter and important colon distension	Proximal loop colostomy 2 weeks of metronidazole 4 × 500 mg IV and ceftriaxone 1 × 2 g IV treatment followed by 6 months of oral amoxicillin 500 mg three times daily

IUD: intrauterine disposif; CT: computed tomography; MRI: magnetic resonance imaging; US: ultrasound; IV: intravenous.

Through our case, we raise the interest of adequate radiological explorations allowing evoking the diagnosis of actinomycosis in face of an infiltrating pelvic mass mimicking a locally advanced tumoral carcinogenic process, especially in the context of the inflammatory syndrome and long-disposed IUD. Our diagnostic and therapeutic approach made it possible to avoid an extirpative and extensive surgery.

Conclusion

Pelvic actinomycosis is a rare pathology that should be considered in any woman with an IUD for several years and who presents with deterioration in general condition, an inflammatory syndrome, and a pelvic tumor syndrome. Ignorance of this entity can lead to a diagnostic delay with the risk of the occurrence of serious complications requiring surgical management. The diagnosis is often histological and could be evoked with adequate radiological exploration. The treatment is essentially medical and based on long-term antibiotic therapy and surgery should be indicated for complicated cases, such as bowel obstruction or unusual radiological presentation of cancer.

Supplemental Material

sj-docx-1-whe-10.1177_17455057231181009 – Supplemental material for Pseudo tumor pelvic actinomycosis revealed by colonic obstruction with hydronephrosis: Can extensive surgery be avoided? A case report

Supplemental material, sj-docx-1-whe-10.1177_17455057231181009 for Pseudo tumor pelvic actinomycosis revealed by colonic obstruction with hydronephrosis: Can extensive surgery be avoided? A case report by Houyem Mansouri, Ines Zemni, Malek souissi, Houda Henchiri, Sabrine Boukhris, Mohamed Ali Ayadi and Leila Achouri in Women’s Health

Footnotes

Acknowledgements

Not applicable.

Declarations

ORCID iD

Ines Zemni

Supplemental material

Supplemental material for this article is available online.

References

Westhoff

IUDs and colonization or infection with

Actinomyces. Contraception 2007; 75: S48–S50.

Elhassani

Babahabib

Kouach

, et al. Actinomycose pelvienne pseudo tumorale associée au dispositif intra-utérin: à propos de trois cas. Pan Afr Med J 2014; 19: 87.

Heo

Shin

Kim

, et al. Imaging of actinomycosis in various organs: a comprehensive review. Radiographics 2014; 34(1): 19–33.

Merki-Feld

Lebeda

Hogg

, et al. The incidence of Actinomyces-like organisms in papanicolaou-stained smears of copper- and levonorgestrel-releasing intrauterine devices. Contraception 2000; 61(6): 365–368.

Saad

Ragab

Ahmed

, et al. Pelvi-abdominal ACTINOMYCOSIS as a complication of long-term use of intrauterine device (IUD). The important role of imaging in diagnosis and follow-up. Radiol Case Rep 2022; 17(11): 4286–4290.

Vasilescu

Târcoveanu

Lupascu

, et al. Abdominopelvic actinomycosis—the diagnostic and therapeutic challenge of the most misdiagnosed disease. Life 2022; 12: 447.

Han

Cao

Zhang

, et al. A case report of pelvic actinomycosis and a literature review. Am J Case Rep 2020; 21: e922601.

Saramago

Cominho

Proença

SSM

, et al. Pelvic actinomycosis mimicking pelvic malignancy. Rev Bras Gynecol Obstet 2019; 41: 463–466.

Laios

Terekh

Majd

, et al. Differentiating pelvic actinomycosis from advanced ovarian cancer: a report of two cases, management reflections and literature review. Gynecol Oncol Res Pract 2014; 1: 5.

10.

Triantopoulou

Van der Molen

Van Es

, et al. Abdominopelvic actinomycosis: spectrum of imaging findings and common mimickers. Acta Radiol Short Rep 2014; 3(2): 2047981614524570.

11.

Lee

Bae

Park

, et al. Pelvic actinomycosis with hydronephrosis and colon stricture simulating an advanced ovarian cancer. J Gynecol Oncol 2008; 19(2): 154–156.

12.

Nissi

Blanco Sequeiros

Lappi-Blanco

, et al. Large bowel obstruction in a young woman simulating a malignant neoplasm: a case report of Actinomyces infection. Case Rep Obstet Gynecol 2013; 2013: 756768.

13.

García-García

Ramírez-Durán

Sandoval-Trujillo

, et al. Pelvic actinomycosis. Can J Infect Dis Med Microbiol 2017; 2017: 9428650.

14.

Mnif

Makni

Khmiri

, et al. Actinomycose pelvienne: a propos de deux cas pelvic [Pelvic actinomycosis: two cases]. Rev Med Interne 2006; 27: 946–949.

15.

Lee

Kim

, et al. Abdominal actinomycosis: CT findings in 10 patients. AJR Am J Roentgenol 1993; 161(4): 791–794.

16.

Najib

Arab

Khazen

, et al. A case of pelvic actinomycosis affecting genital, urinary and digestive tracts: a rare misleading diagnosis. Future Sci OA 2021; 7(8): FSO740.

17.

Nasu

Matsumoto

Yoshimatsu

, et al. Ureteral and sigmoid obstruction caused by pelvic actinomycosis in an intrauterine contraceptive device user. Gynecol Obstet Invest 2002; 54(4): 228–231.

18.

Haj

Nasser

Loberant

, et al. Pelvic actinomycosis presenting as ureteric and rectal stricture. Dig Surg 2000; 17(4): 414–417.

19.

Akhan

Dogan

Akhan

, et al. Pelvic actinomycosis mimicking ovarian malignancy: three cases. Eur J Gynaecol Oncol 2008; 29: 294–297.

20.

Lee

Park

, et al. Abdominopelvic actinomycosis involving the gastrointestinal tract: CT features. Radiology 2001; 220(1): 76–80.

21.

Könönen

Wade

WG.

Actinomyces and related organisms in human infections. Clin Microbiol Rev 2015; 28: 419–442.

22.

Morais-Kansaon

Antonacci-Condessa

Andrade- Ribeiro

, et al. Pseudotumor colónico causado por actinomicosis abdominal: reporte de un caso. Cir Cir 2020; 88: 4077.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.04 MB